In the Media
The New Reality Starts to Hit Home (ATPblog)
This month’s ATPblog looks at the industry view on business models based on presentations from the recent EuroBiotech Forum in Paris.
Value creation: Pure plays vs Hybrids? (ATPblog)
This month’s ATPblog is all about extending the search for value: both in business models and in a biotech company stock.
Another grim day for big science - ATP Blog
ATPBio, is consultancy firm providing strategic insight and transaction support to the life sciences industry. www.atpbio.com
Declining Exclusivity: are Patents now Redundant?
In this month’s ATPblog, David Cavalla, a Principal at ATPBio, examines the drug innovator’s use of patents and finds monopoly periods are declining.
A Penny for your Thoughts
In this month’s ATPblog, they consider ways to improve commercialisation of early stage life sciences technologies. In particular, how important is it to consider the market need early on? How can you improve the screening of opportunities to highlight the ones with best potential?
A Pharma Stock - Approach to value investing
This months ATPblog
To be or not to be: The Pros and Cons of the Virtual Biotech Company
In establishing and building a biotech company, just how far can you go on a virtual model?
Creative Financing - in a brave new world
Raman Minhas, CEO of ATPBio, looks at what avenues companies can use to raise financing in addition to the usual approaches to VCs and other investors?
M&A Trials: Importing a Culture
Raman Minhas, CEO of ATPBio, looks at at one of the key issues that arises in any M&A transaction – getting the culture right.
The PharmaTimes Recruitment Business Forum
Carolyn Douthwaite of PiR Interims highlights the value of the The PharmaTimes Recruitment Business Forum
In Praise of Interims
As reported in Pharmaceutical Executive, Carolyn Douthwaite outlines how Interim managers can be hired for a specific project or to cover a transitional period.
Interims Still Get a Bad Name, The Recruiter Magazine, September issue 07, Reporter Ben Jones
Interim managers are still seen as a threat by some companies who have a negative image of the job they do, according to the managing director of PiR Interims.
The interim: a new kind of manager
Becoming an interim is proving an attractive career option for many managers - and companies also benefit from this style of working, says John Hosken